Neonatal sepsis and antibiotic resistance in developing countries.

M. Bates,Mwila Kabwe,Alimuddin Zumla

DOI: https://doi.org/10.1097/INF.0000000000000388

2014-10-01

The Pediatric Infectious Disease Journal

Abstract:

What problem does this paper attempt to address?

Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries

Kirsty Sands,Maria J. Carvalho,Edward Portal,Kathryn Thomson,Calie Dyer,Chinenye Akpulu,Robert Andrews,Ana Ferreira,David Gillespie,Thomas Hender,Kerenza Hood,Jordan Mathias,Rebecca Milton,Maria Nieto,Khadijeh Taiyari,Grace J. Chan,Delayehu Bekele,Semaria Solomon,Sulagna Basu,Pinaki Chattopadhyay,Suchandra Mukherjee,Kenneth Iregbu,Fatima Modibbo,Stella Uwaezuoke,Rabaab Zahra,Haider Shirazi,Adil Muhammad,Jean-Baptiste Mazarati,Aniceth Rucogoza,Lucie Gaju,Shaheen Mehtar,Andre N. H. Bulabula,Andrew Whitelaw,Timothy R. Walsh,

DOI: https://doi.org/10.1038/s41564-021-00870-7

IF: 28.3

2021-03-29

Nature Microbiology

Abstract:Abstract Antimicrobial resistance in neonatal sepsis is rising, yet mechanisms of resistance that often spread between species via mobile genetic elements, ultimately limiting treatments in low- and middle-income countries (LMICs), are poorly characterized. The Burden of Antibiotic Resistance in Neonates from Developing Societies (BARNARDS) network was initiated to characterize the cause and burden of antimicrobial resistance in neonatal sepsis for seven LMICs in Africa and South Asia. A total of 36,285 neonates were enrolled in the BARNARDS study between November 2015 and December 2017, of whom 2,483 were diagnosed with culture-confirmed sepsis. Klebsiella pneumoniae ( n = 258) was the main cause of neonatal sepsis, with Serratia marcescens ( n = 151), Klebsiella michiganensis ( n = 117), Escherichia coli ( n = 75) and Enterobacter cloacae complex ( n = 57) also detected. We present whole-genome sequencing, antimicrobial susceptibility and clinical data for 916 out of 1,038 neonatal sepsis isolates (97 isolates were not recovered from initial isolation at local sites). Enterobacterales ( K. pneumoniae, E. coli and E. cloacae ) harboured multiple cephalosporin and carbapenem resistance genes. All isolated pathogens were resistant to multiple antibiotic classes, including those used to treat neonatal sepsis. Intraspecies diversity of K. pneumoniae and E. coli indicated that multiple antibiotic-resistant lineages cause neonatal sepsis. Our results will underpin research towards better treatments for neonatal sepsis in LMICs.

microbiology
Prevalence of Multidrug-Resistant Pathogens Causing Neonatal Early and Late Onset Sepsis, a Retrospective Study from the Tertiary Referral Children’s Hospital

Panpan Fang,Kaijie Gao,Junmei Yang,Tiewei Li,Weihua Gong,Qianqian Sun,Yingyuan Wang

DOI: https://doi.org/10.2147/idr.s416020

2023-01-01

Infection and Drug Resistance

Abstract:Introduction:Sepsis is the most severe infectious disease with the highest mortality rate, particularly among neonates admitted to the neonatal intensive care unit (NICU). This study retrospectively analyzed the epidemiology, antibiotic resistance profiles, and prevalence of multidrug-resistant (MDR) bacteria isolated from blood or cerebrospinal fluid (CSF) cultures in order to evaluate the appropriateness of initial empirical therapy for neonatal sepsis.Methods:A retrospective study was conducted in the NICU from January 1, 2015, to December 31, 2022. Microbiological data from patients admitted to the NICU were anonymously extracted from the Laboratory of Microbiology database. Neonatal sepsis was classified into two types: early-onset sepsis (EOS), which occurs within the first 72 hours of life, and late-onset sepsis (LOS) for those begins later.Results:A total of 679 bacterial strains, 543 from blood and 136 from CSF, were detected in 631 neonates. Among these, 378 isolates (55.67%) were Gram-positive bacteria, and 301 isolates (44.33%) were Gram-negative bacteria. The most frequently isolated pathogens were Coagulase-negative staphylococci (CoNS) (36.52%), followed by Klebsiella pneumoniae (20.47%) and Escherichia coli (13.84%). In EOS, 121 strains were found, CoNS represented the majority (33.88%), followed by Klebsiella pneumoniae (23.97%) and Escherichia coli (8.26%). Early-onset septicemia exhibited 67 (55.37%) MDR bacteria. In LOS, 558 strains were isolated, CoNS represented the majority of pathogens (37.10%), followed by Klebsiella pneumoniae (19.71%) and Escherichia coli (15.05%). Late-onset septicemia showed 332 (59.50%) MDR bacteria. High rates of MDR were found in CoNS (76.21%), carbapenem-resistant Klebsiella pneumoniae (66.91%), and MRSA (33.33%).Conclusion:The study revealed an alarming prevalence of MDR strains isolated from neonatal sepsis, emphasizing the necessity of finding effective prevention and treatment measures. Colistin can be used for MDR Gram-negative bacteria, while vancomycin and teicoplanin can be considered treatment therapies for staphylococcal infections.
Neonatal sepsis in low-income countries: epidemiology, diagnosis and prevention

Constantin Radu Popescu,Miranda M. M. Cavanagh,Bentry Tembo,Msandeni Chiume,Norman Lufesi,David M. Goldfarb,Niranjan Kissoon,Pascal M. Lavoie

DOI: https://doi.org/10.1080/14787210.2020.1732818

2020-02-25

Abstract:<span><b>Introduction</b>: Sepsis accounts for up to one-third of neonatal deaths in the world each year. The World Health Organization acknowledges neonatal sepsis as a major global health concern, and that the highest burden occurs in low- and middle-income countries (LMICs). Despite major research and clinical progress in this area, we still lack accurate diagnostic tools for neonatal sepsis, complicating the management of this condition.<b>Areas covered</b>: The purpose here is to review the latest data on the incidence, diagnosis, prevention, and management of neonatal sepsis in LMIC. We discuss the limitations of current diagnostic tests – including their lack of availability – and how this may influence global estimates of cases. We review the benefits of antenatal, intrapartum, and post-natal preventive measures. We briefly discuss the management, highlighting the emergence of antimicrobial resistance. Finally, we expose some high priority areas.<b>Expert opinion</b>: Neonatal sepsis is a challenging condition requiring a multifaceted approach to address the major diagnostic issues, but also the underlying socio-economic causes that nourish epidemic cases in LMIC. Focusing on antibiotics as a main pillar of intervention is likely to engender antimicrobial resistance, eventually hindering the appreciable gains LMICs have achieved in neonatal health outcomes.</span>

pharmacology & pharmacy,infectious diseases,microbiology
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries

Biljana Kakaraskoska Boceska,Tuba Vilken,Basil Britto Xavier,Tomislav Kostyanev,Qiang Lin,Christine Lammens,Sally Ellis,Seamus O'Brien,Renata Maria Augusto da Costa,Aislinn Cook,Neal Russell,Julia Bielicki,Amy Riddell,Wolfgang Stohr,Ann Sarah Walker,Eitan Naaman Berezin,Emmanuel Roilides,Maia De Luca,Lorenza Romani,Daynia Ballot,Angela Dramowski,Jeannette Wadula,Sorasak Lochindarat,Suppawat Boonkasidecha,Flavia Namiiro,Hoang Thi Bich Ngoc,Minh Dien Tran,Tim R Cressey,Kanchana Preedisripipat,James A Berkley,Robert Musyimi,Charalampos Zarras,Trusha Nana,Andrew Whitelaw,Cely Barreto da Silva,Prenika Jaglal,Willy Ssengooba,Samir K Saha,Mohammad Shahidul Islam,Marisa Marcia Mussi-Pinhata,Cristina Gardonyi Carvalheiro,Laura J V Piddock,Paul T Heath,Surbhi Malhotra-Kumar,Michael Sharland,Youri Glupczynski,Herman Goossens

DOI: https://doi.org/10.1038/s41467-024-48296-z

2024-05-10

Abstract:Gram-negative bacteria (GNB) are a major cause of neonatal sepsis in low- and middle-income countries (LMICs). Although the World Health Organization (WHO) reports that over 80% of these sepsis deaths could be prevented through improved treatment, the efficacy of the currently recommended first- and second-line treatment regimens for this condition is increasingly affected by high rates of drug resistance. Here we assess three well known antibiotics, fosfomycin, flomoxef and amikacin, in combination as potential antibiotic treatment regimens by investigating the drug resistance and genetic profiles of commonly isolated GNB causing neonatal sepsis in LMICs. The five most prevalent bacterial isolates in the NeoOBS study (NCT03721302) are Klebsiella pneumoniae, Acinetobacter baumannii, E. coli, Serratia marcescens and Enterobacter cloacae complex. Among these isolates, high levels of ESBL and carbapenemase encoding genes are detected along with resistance to ampicillin, gentamicin and cefotaxime, the current WHO recommended empiric regimens. The three new combinations show excellent in vitro activity against ESBL-producing K. pneumoniae and E. coli isolates. Our data should further inform and support the clinical evaluation of these three antibiotic combinations for the treatment of neonatal sepsis in areas with high rates of multidrug-resistant Gram-negative bacteria.
Neonatal Sepsis Due to Multidrug-resistant Bacteria at a Tertiary Teaching Hospital in Ethiopia

Mulatu Gashaw,Solomon Ali,Melkamu Berhane,Getnet Tesfaw,Beza Eshetu,Netsanet Workneh,Thomas Seeholzer,Guenter Froeschl,Arne Kroidl,Andreas Wieser,Esayas Kebede Gudina

DOI: https://doi.org/10.1097/inf.0000000000004364

2024-04-24

Abstract:Background: The burden of multidrug-resistant bacterial infections in low-income countries is alarming. This study aimed to identify the bacterial etiologies and antibiotic resistance patterns among neonates in Jimma, Ethiopia. Methods: An observational longitudinal study was conducted among 238 presumptive neonatal sepsis cases tested with blood and/or cerebrospinal fluid culture. The bacterial etiologies were confirmed using matrix-assisted laser desorption ionization-time of flight mass spectrometry. The antibiotic resistance patterns were determined using the automated disc diffusion method (Bio-Rad) and the results were interpreted based on the European Committee on Antimicrobial Susceptibility Testing 2021 breakpoints. Extended-spectrum β-lactamases were detected using a double disc synergy test and confirmed by Mast discs (Mast Diagnostica GmbH). Results: A total of 152 pathogens were identified. Of these, Staphylococcus aureus (18.4%) was the predominant isolate followed by Klebsiella pneumoniae (15.1%) and Escherichia coli (10.5%). All the isolates exhibited a high rate of resistance to first- and second-line antibiotics ranging from 73.3% for gentamicin to 93.3% for ampicillin. Furthermore, 74.4% of the Gram-negative isolates were extended-spectrum β-lactamase producers and 57.1% of S. aureus strains were methicillin resistant. The case fatality rate was 10.1% and 66.7% of the deaths were attributable to infections by multidrug-resistant pathogens. Conclusions: The study revealed a high rate of infections with multidrug-resistant pathogens. This poses a significant challenge to the current global and national target to reduce neonatal mortality rates. To address these challenges, it is important to employ robust infection prevention practices and continuous antibiotic resistance testing to allow targeted therapy.

pediatrics,immunology,infectious diseases
Gram-Negative Neonatal Sepsis in Low- and Middle- Income Countries: How Appropriate are the WHO Recommended Empirical Sepsis Antibiotic Regimens? A Systematic Review and Meta-Analysis

Sophie CH Wen,Yukiko Ezure,Lauren Rolley,Geoff Spurling,Colleen L. Lau,David L. Paterson,Adam D. Irwin

DOI: https://doi.org/10.2139/ssrn.3777180

2021-01-01

SSRN Electronic Journal

Abstract:Background: Neonatal sepsis is a significant global health issue associated with marked regional disparities in mortality. Antimicrobial resistance (AMR) is a growing concern in Gram-negative organisms which increasingly predominate in neonatal sepsis, and existing WHO empirical antibiotic recommendations may no longer be appropriate. Previous systematic reviews have been limited to specific low- and middle-income countries (LMICs). We therefore completed a systematic review and meta-analysis of available data from all LMICs since 2010, with a focus on regional differences in Gram-negative infections and AMR.Methods: All studies published from 2010 with microbiologically confirmed bloodstream infections or meningitis in neonates and AMR from LMICs were assessed for eligibility. Small case series or number of Gram-negative isolates (<10), and studies with a majority of isolates prior to 2010 were excluded. Main outcomes were pooled proportions of E.coli, Klebsiella, Enterobacter, Pseudomonas, Acinetobacter and AMR.Findings: We included 75 studies comprising 17,066 positive blood cultures from 16 LMICs. No studies were identified outside of Africa and Asia. The estimated pooled proportion of neonatal sepsis caused by Gram-negative organisms was 60% (95% CI 54-65%). Klebsiella spp was the most common, with a pooled proportion of 37% of Gram-negative sepsis (95% CI 32-43%). Resistance to aminoglycosides and 3rd generation cephalosporins ranged from 42-69% and 59-84%, respectively.Interpretation: Gram-negative bacteria are an important cause of neonatal sepsis in LMICs and associated with significant rates of resistance to WHO recommended first and second line empirical antibiotics. AMR surveillance should underpin region-specific empirical treatment recommendations. Meanwhile, a significant global commitment to accessible and effective antimicrobials for neonates is required. Funding Statement: Sophie CH Wen is supported by a Queensland Health Clinical Research Fellowship. Geoff Spurling, David L Paterson, Adam D Irwin, and Colleen L Lau are supported by National Health and Medical Research Council (NHMRC) Investigator Grants.Declaration of Interests: None to declare.
Etiology of Bacterial Sepsis and Isolate Resistance Patterns in Hospitalized Neonates in Zambia

Franklyn N Egbe,Carter Cowden,Lawrence Mwananyanda,Cassandra Pierre,James Mwansa,Chileshe Lukwesa Musyani,Angela Lyondo,Monica L Kapasa,Sylvia Machona,Moses M Chilufya,Gertrude Munanjala,Susan E Coffin,Davidson H Hamer,Matthew A Bates

DOI: https://doi.org/10.1097/INF.0000000000004008

2023-10-01

Abstract:Background: The Sepsis Prevention in Neonates in Zambia study is a prospective cohort study that evaluated an infection prevention and control (IPC) bundle in the University Teaching Hospital neonatal intensive care unit (NICU) in Lusaka, Zambia. We present here the etiologies, antimicrobial resistance profiles, and associated mortality of bloodstream infections (BSI) in this cohort. Methods: Venous blood was collected from neonates with clinically suspected sepsis and cultured with an automated blood culture system. Organism identification and susceptibility testing were done using the Vitek II system. We used the CDC National Health Safety Network criteria to define pathogens and commensals. Results: There were 1120 blood cultures performed for 1060 neonates with suspected sepsis. Overall, 38% (424/1120) of cultures were positive of which 72% (306/424) grew pathogens. Blood cultures obtained after, as compared to before, 2 days of hospitalization were more likely to yield a pathogen (77% vs. 65%; P < 0.001). Klebsiella pneumoniae was the most prevalent organism, accounting for 74% (225/306) of all pathogens . K. pneumoniae isolates were highly resistant: 98% (221/225) were extended-spectrum beta-lactamase (ESBL)-positive, while 81% were resistant to gentamicin (182/225) and fluoroquinolones (177/219). Only one isolate was carbapenem resistant. Observed mortality rate was 32% (122/380); 61% (75/122) of the deaths was related to Klebsiella BSI. Conclusions: Multidrug-resistant ESBL-producing Klebsiella species were the main organisms responsible for BSI and were associated with increased mortality. BSI risk increased with prolonged hospitalization, underscoring the importance of IPC measures in the NICU.
Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome

Tumaini V Mhada,Francis Fredrick,Mecky I Matee,Augustine Massawe

DOI: https://doi.org/10.1186/1471-2458-12-904

IF: 4.5

2012-10-24

BMC Public Health

Abstract:Background: Neonatal sepsis contributes significantly to morbidity and mortality among young infants. The aetiological agents as well as their susceptibility to antimicrobial agents are dynamic. This study determined aetiology, antimicrobial susceptibility and clinical outcome of neonatal sepsis at Muhimbili National Hospital. Methods: Three hundred and thirty neonates admitted at the Muhimbili National Hospital neonatal ward between October, 2009 and January, 2010 were recruited. Standardized questionnaires were used to obtain demographic and clinical information. Blood and pus samples were cultured on MacConkey, blood and chocolate agars and bacteria were identified based on characteristic morphology, gram stain appearance and standard commercially prepared biochemical tests. Antimicrobial sensitivity testing was performed for ampicillin, cloxacillin, gentamicin, amikacin, cefuroxime and ceftriaxone on Mueller Hinton agar using the Kirby Bauer diffusion method. Results: Culture proven sepsis was noted in 24% (74/330) of the study participants. Isolated bacterial pathogens were predominantly Staphylococcus aureus, Klebsiella spp and Escherichia coli. Klebsiella spp 32.7% (17/52) was the predominant blood culture isolate in neonates aged below seven days while Staphylococcus aureus 54.5% (12/22) was commonest among those aged above seven days. Staphylococcus aureus was the predominant pus swabs isolate for both neonates aged 0-6 days 42.2% (98/232) and 7-28 days 52.3% (34/65). Resistance of blood culture isolates was high to ampicillin 81.1% (60/74) and cloxacillin 78.4% (58/74), moderate to ceftriaxone 14.9% (11/74) and cefuroxime 18.9% (14/74), and low to amikacin 1.3% (1/74). Isolates from swabs had high resistance to ampicillin 89.9% (267/297) and cloxacillin 85.2 (253/297), moderate resistance to ceftriaxone 38.0% (113/297) and cefuroxime 36.0% (107/297), and low resistance to amikacin 4.7% (14/297). Sepsis was higher in neonates with fever and hypothermia (p=0.02), skin pustules (p<0.001), umbilical pus discharge and abdominal wall hyperemia (p=0.04). Presence of skin pustules was an independent predictor of sepsis OR 0.26, 95% CI (0.10-0.66) p=0.004. The overall death rate was 13.9% (46/330), being higher in neonates with sepsis 24.3% (18/74) than those without 10.9% (28/256), p=0.003. Conclusions: Staphylococcus aureus was predominant isolate followed by Klebsiella and Escherichia coli. There was high resistance to ampicillin and cloxacillin. Mortality rate due to neonatal sepsis was high in our setting. Routine antimicrobial surveillance should guide the choice of antibiotics for empirical treatment of neonatal sepsis.
Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis

Sophie C. H. Wen,Yukiko Ezure,Lauren Rolley,Geoff Spurling,Colleen L. Lau,Saba Riaz,David L. Paterson,Adam D. Irwin

DOI: https://doi.org/10.1371/journal.pmed.1003787

2021-09-28

PLoS Medicine

Abstract:Background Neonatal sepsis is a significant global health issue associated with marked regional disparities in mortality. Antimicrobial resistance (AMR) is a growing concern in Gram-negative organisms, which increasingly predominate in neonatal sepsis, and existing WHO empirical antibiotic recommendations may no longer be appropriate. Previous systematic reviews have been limited to specific low- and middle-income countries. We therefore completed a systematic review and meta-analysis of available data from all low- and lower-middle-income countries (LLMICs) since 2010, with a focus on regional differences in Gram-negative infections and AMR. Methods and findings All studies published from 1 January 2010 to 21 April 2021 about microbiologically confirmed bloodstream infections or meningitis in neonates and AMR in LLMICs were assessed for eligibility. Small case series, studies with a small number of Gram-negative isolates (<10), and studies with a majority of isolates prior to 2010 were excluded. Main outcomes were pooled proportions of Escherichia coli , Klebsiella , Enterobacter , Pseudomonas , Acinetobacter and AMR. We included 88 studies (4 cohort studies, 3 randomised controlled studies, and 81 cross-sectional studies) comprising 10,458 Gram-negative isolates from 19 LLMICs. No studies were identified outside of Africa and Asia. The estimated pooled proportion of neonatal sepsis caused by Gram-negative organisms was 60% (95% CI 55% to 65%). Klebsiella spp. was the most common, with a pooled proportion of 38% of Gram-negative sepsis (95% CI 33% to 43%). Regional differences were observed, with higher proportions of Acinetobacter spp. in Asia and Klebsiella spp. in Africa. Resistance to aminoglycosides and third-generation cephalosporins ranged from 42% to 69% and from 59% to 84%, respectively. Study limitations include significant heterogeneity among included studies, exclusion of upper-middle-income countries, and potential sampling bias, with the majority of studies from tertiary hospital settings, which may overestimate the burden caused by Gram-negative bacteria. Conclusions Gram-negative bacteria are an important cause of neonatal sepsis in LLMICs and are associated with significant rates of resistance to WHO-recommended first- and second-line empirical antibiotics. AMR surveillance should underpin region-specific empirical treatment recommendations. Meanwhile, a significant global commitment to accessible and effective antimicrobials for neonates is required.

medicine, general & internal
Introduction to injury and repair of microbial cells.

F. Busta

DOI: https://doi.org/10.1016/S0065-2164(08)70069-8

Advances in Applied Microbiology

Abstract:
Changing Landscape of Antimicrobial Resistance in Neonatal Sepsis: An in silico Analyses of Multidrug Resistance in Klebsiella pneumoniae

Santhiya Vijayakumar,Hithesh Kumar,Soumya Basu,Sara Chandy,Anand Anbarasu,Anand Manoharan,Sudha Ramaiah

DOI: https://doi.org/10.1097/inf.0000000000004358

2024-04-12

Abstract:Background: Neonatal sepsis poses a critical healthcare concern, as multidrug-resistant Klebsiella pneumoniae ( K. pneumoniae ) infections are on the rise. Understanding the antimicrobial susceptibility patterns and underlying resistance mechanism is crucial for effective treatment. Objectives: This study aimed to comprehensively investigate the antimicrobial susceptibility patterns of K. pneumoniae strains responsible for neonatal sepsis using in silico tools. We sought to identify trends and explore reasons for varying resistance levels, particularly for β-lactams and fluoroquinolone. Methods: K. pneumoniae isolated from neonates at Kanchi Kamakoti CHILDS Trust Hospital (2017–2020) were analyzed for antimicrobial resistance. Elevated resistance to β-lactam and fluoroquinolone antibiotics was further investigated through molecular docking and interaction analysis. β-lactam affinity with penicillin-binding proteins and β-lactamases was examined. Mutations in ParC and GyrA responsible for quinolone resistance were introduced to investigate ciprofloxacin interactions. Results: Of 111 K. pneumoniae blood sepsis isolates in neonates, high resistance was detected to β-lactams such as cefixime (85.91%, n = 71), ceftriaxone (84.9%, n = 106), cefotaxime (84.9%, n = 82) and fluoroquinolone (ciprofloxacin- 79.44%, n = 107). Molecular docking revealed low β-lactam binding toward penicillin-binding proteins and higher affinities for β-lactamases, attributing to the reduced β-lactam efficiency. Additionally, ciprofloxacin showed decreased affinity toward mutant ParC and GyrA in comparison to their corresponding wild-type proteins. Conclusion: Our study elucidates altered resistance profiles in neonatal sepsis caused by K. pneumoniae, highlighting mechanisms of β-lactam and fluoroquinolone resistance. It underscores the urgent need for the development of sustainable therapeutic alternatives to address the rising antimicrobial resistance in neonatal sepsis.

pediatrics,immunology,infectious diseases
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria

Christopher A Darlow,Renata M A da Costa,Sally Ellis,François Franceschi,Mike Sharland,Laura Piddock,Shampa Das,William Hope

DOI: https://doi.org/10.1007/s40272-021-00465-z

Abstract:Neonatal sepsis causes up to an estimated 680,000 deaths annually worldwide, predominantly in low- and middle-income countries (LMICs). A significant and growing proportion of bacteria causing neonatal sepsis are resistant to multiple antibiotics, including the World Health Organization-recommended empiric neonatal sepsis regimen of ampicillin/gentamicin. The Global Antibiotic Research and Development Partnership is aiming to develop alternative empiric antibiotic regimens that fulfil several criteria: (1) affordable in LMIC settings; (2) activity against neonatal bacterial pathogens, including extended-spectrum β-lactamase producers, gentamicin-resistant Gram-negative bacteria, and methicillin-resistant Staphylococcus aureus (MRSA); (3) a licence for neonatal use or extensive experience of use in neonates; and (4) minimal toxicities. In this review, we identify five antibiotics that fulfil these criteria: amikacin, tobramycin, fosfomycin, flomoxef, and cefepime. We describe the available characteristics of each in terms of mechanism of action, resistance mechanisms, clinical pharmacokinetics, pharmacodynamics, and toxicity profile. We also identify some knowledge gaps: (1) the neonatal pharmacokinetics of cefepime is reliant on relatively small and limited datasets, and the pharmacokinetics of flomoxef are also reliant on data from a limited demographic range and (2) for all reviewed agents, the pharmacodynamic index and target has not been definitively established for both bactericidal effect and emergence of resistance, with many assumed to have an identical index/target to similar class molecules. These five agents have the potential to be used in novel combination empiric regimens for neonatal sepsis. However, the data gaps need addressing by pharmacokinetic trials and pharmacodynamic characterisation.
Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients.

D. Stanček,J. Robenský

1979-03-01

Acta Virologica

Abstract:Two groups of 22 patients suffering from either systemic lupus erythematosus (SLE) or infectious mononucleosis (IM) were checked for Epstein-Barr virus capsid antigen antibody (EB-VCA) production. The average significant antibody levels as well as the frequency of their occurrence were clearly higher in SLE than in IM patients.
Identification of potential novel combination antibiotic regimens based on drug-susceptibility and genetic diversity of Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries

Biljana Kakaraskoska Boceska,Tuba Vilken,Basil Britto Xavier,Christine Lammens,Sally Ellis,Seamus O`Brien,Renata Maria Augusto da Costa,Aislinn Cook,Neal J Russell,Julia Bielicki,Eitan Naaman Berezin,Emmanual Roilides,Maia De Luca,Lorenza Romani,Daynia Ballot,Angela Dramowski,Jeannette Wadula,Sorasak Lochindarat,Suppawat Boonkasidecha,Flavia Namiiro,Hoang Thi Bich Ngoc,Tran Minh Dien,Tim R. Cressey,Kanchana Preedisripipat,James A Berkley,Robert Musyimi,Charalampos Zarras,Trusha Nana,Andrew Whitelaw,Cely Barreto da Silva,Prenika Jaglal,Willy Ssengooba,Samir K. Saha,Mohammad Shahidul Islam,Marisa Marcia Mussi-Pinhata,Cristina Gardony Carvalheiro,Laura Piddock,Surbhi Malhotra-Kumar,Mike Sharland,Youri Glupczynski,Herman Goossens,Kakaraskoska Boceska,B.,Vilken,T.,Xavier,B. B.,Lammens,C.,Ellis,S.,O`Brien,S.,da Costa,R. M. A.,Cook,A.,Russell,N. J.,Bielicki,J.,Berezin,E. N.,Roilides,E.,De Luca,M.,Romani,L.,Ballot,D.,Dramowski,A.,Wadula,J.,Lochindarat,S.,Boonkasidecha,S.,Namiiro,F.,Thi Bich Ngoc,H.,Minh Dien,T.,Cressey,T. R.,Preedisripipat,K.,Berkley,J. A.,Musyimi,R.,Zarras,C.,Nana,T.,Whitelaw,A.,da Silva,C. B.,Jaglal,P.,Ssengooba,W.,Saha,S. K.,Islam,M. S.,Mussi-Pinhata,M. M.,Carvalheiro,C. G.,Piddock,L.,Malhotra-Kumar,S.,Sharland,M.,Glupczynski

DOI: https://doi.org/10.1101/2023.10.20.23296805

2023-10-25

MedRxiv

Abstract:Objectives: Several recent studies highlight the high prevalence of resistance to multiple antibiotic classes used in current treatment regimens for neonatal sepsis and new treatment options are urgently needed. We aimed to identify potential new combination antibiotic treatment regimens by investigating the drug-resistance and genetic profiles of the most frequently isolated Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries (LMICs) in the NeoOBS study. Material and methods: Gram-negative bacteria isolated from neonates with culture-confirmed sepsis from 13 clinical sites in nine countries, mainly LMICs, were analyzed. Culture-based identification was followed by whole-genome sequencing (WGS). Minimal inhibitory concentrations (MICs) for 8 antibiotics were determined for a representative subset of 108 isolates. Results: Five bacterial species, Klebsiella pneumoniae (n=135), Acinetobacter baumannii (n=80), Escherichia coli (n=34), Serratia marcescens (n=33) and Enterobacter cloacae complex (ECC) (n=27) accounted for most Gram-negative bacterial isolates received (309/420, 74%). Extended-spectrum {beta}-lactamases (ESBL) genes mostly belonging to CTX-M-15 were found in 107 (79%) K. pneumoniae isolates and 13 (38%) E. coli, as well as in 6 (18%) and 10 (37%) S. marcescens and ECC isolates, respectively. Carbapenem resistance genes were present in 41 (30%) K. pneumoniae, while 73 (91%) of A. baumannii isolates were predicted to be MDR based on carbapenem resistance genes. Apart from A. baumannii, in which two major pandemic lineages predominated, a wide genetic diversity occurred at the intraspecies level with different MDR clones occurring at the different sites. Phenotypic testing showed resistance to the WHO first- and second- line recommended treatment regimens: 74% of K. pneumoniae isolates were resistant to gentamicin and 85% to cefotaxime; E. coli isolates showed resistance to ampicillin, gentamicin and cefotaxime in 90%, 38% and 47%, respectively. For the novel antibiotic regimens involving different combinations of flomoxef, fosfomycin and amikacin, the overall predicted MIC-determined susceptibility for Enterobacterales isolates was 71% (n=77) to flomoxef-amikacin, 76% (n=82) to flomoxef-fosfomycin and 79% (n=85) to fosfomycin-amikacin combinations, compared to 31% and 22% isolates susceptible to ampicillin-gentamicin and cefotaxime, respectively. ESBL-producing Enterobacterales isolates were 100% susceptible both to flomoxef-fosfomycin and flomoxef-amikacin and 92% to fosfomycin-amikacin. Conclusion: Enterobacterales carried multiple resistance genes to cephalosporins, carbapenems and aminoglycosides. ESBL-producing K. pneumoniae and E. coli isolates were highly susceptible to the three new antibiotic combination regimens planned to be evaluated in the currently recruiting GARDP-sponsored NeoSep1 trial.

English Else
Efficient solutions in V-KT-pseudoinvex multiobjective control problems: A characterization

M. Arana-Jiménez,A. Rufián-Lizana,Gabriel Ruiz Garzón,Rafaela Osuna Gómez

DOI: https://doi.org/10.1016/j.amc.2009.05.060

IF: 4.397

2009-09-01

Applied Mathematics and Computation

Abstract:
The current and future roles of neonatal infection surveillance programmes in combating antimicrobial resistance

Benjamin Cailes,Stefania Vergnano,Christina Kortsalioudaki,Paul Heath,Mike Sharland

DOI: https://doi.org/10.1016/j.earlhumdev.2015.08.012

Abstract:Neonatal sepsis is an important cause of morbidity and mortality, particularly in premature or low birth weight babies. Hospital-acquired blood stream infections represent a significant and largely preventable cause of disease in this population. Neonatal units have been identified as a common site for the development and transmission of antimicrobial-resistant pathogens, a significant issue in modern medicine. Neonatal surveillance programmes collect prospective data on infection rates and may be used to optimise therapy, benchmark practice and develop quality improvement programmes. Despite this, the number of networks is relatively few and these are largely concentrated in resource-rich nations. Furthermore, surveillance definitions may vary between programmes impairing our ability to draw comparisons between them. Better harmonisation is required between networks to ensure that they achieve their potential as a valuable tool for benchmarking of hospital-acquired infection rates between units.
Neonatal bacteremia in a neonatal intensive care unit: analysis of causative organisms and antimicrobial susceptibility

A Hafsa,M Fakruddin,MA Hakim,JD Sharma

DOI: https://doi.org/10.3329/bjms.v10i3.8363

Bangladesh Journal of Medical Science

Abstract:Background: Bangladesh has a neonatal death rate that is substantially high and demands urgent attention. Objective: This retrospective study was performed to determine the incidence of bacterial neonatal sepsis condition in the Chittagong area of Bangladesh with focus on various demographic characteristics of neonates, causative organisms and their antibiotic susceptibility. Methodology: Blood culture was performed on all neonates with risk factors or signs of suggestive sepsis. Blood samples were cultured using tryptone soya broth (TSB- blood broth) according to standard method. Results: From the 1400 neonates 104 had positive blood culture for neonatal sepsis infection. Among the infected children 40 (38.46%) were born in the hospital and 64 (61.54%) were born at home. The EONS (Early Onset Neonatal Sepsis) accounted for 68 (65.38%) and LONS (Late Onset Neonatal Sepsis) accounted for 36 (34.62%). Among the isolated organism Klebsiella pneumoniae accounted for 79 (75.96%), Serratia marcescens 19 (18.27%), Pseudomonas aeruginosa 04 (3.85%) and Staphylococcus aureus accounted for 02 (1.92%). Among the isolated species 102 were attributed to G (-ve) bacteria and 02 were attributed to G (+ve) bacteria. Most of the G (-ve) bacteria showed resistance to commonly used antibiotics such as ampicillin, ceftriaxon and gentamicin. In this study all isolates showed sensitivity to the imipenem. Conclusion: Collection of up-to-date data is mandatory for appropriate use of antibiotics. Key words: Neonatal sepsis, Interleukin-6, antibiotics, susceptibility. DOI: http://dx.doi.org/10.3329/bjms.v10i3.8363 BJMS 2011; 10(3): 187-194
Technical considerations when obtaining and interpreting prostatic biopsies from men with suspicion of early prostate cancer: Part I

B. Chappell,J. McLoughlin

DOI: https://doi.org/10.1111/j.1464-410X.2005.05538.x

2005-06-01

BJU International

Abstract:A lower threshold of 2.5 ng/mL has become increasingly popular in an effort to increase the chances of cancer being curable at diagnosis Cancer detection rates of 22–27% have been reported in men with a tPSA of 2.5–4 ng/mL [4,8–10]. In this range, tPSA has a sensitivity of 67–80% and a PPV of ≈ 22% [4]. In lowering the threshold the number of men undergoing unnecessary TRUS-B has increased, leading some authors to question whether tumours detected in this tPSA range are clinically significant. Such tumours are associated with more favourable pathological features [11], but even at this tPSA level aggressive pathology is encountered. To illustrate this, a recent study by Sokoloff et al. [12] reviewed histology from a series of 79 men who presented with a tPSA of <4 ng/mL and subsequently underwent radical prostatectomy (RP). From this group, 13 men had a final Gleason score of ≥ 7 and 20 had extraprostatic tumour extension.
Antibiotic resistance in neonates in China 2012–2019: A multicenter study

Jintong Tan,Yiwen Wang,Xiaohui Gong,Jing Li,Wenhua Zhong,Liqin Shan,Xiaoping Lei,Qian Zhang,Qin Zhou,Youyan Zhao,Chao Chen,Yongjun Zhang

DOI: https://doi.org/10.1016/j.jmii.2021.05.004

2021-05-01

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>To investigate antibiotic resistance of pathogens responsible for neonatal invasive bacterial infections(IBIs) in China.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Cross-sectional study of neonates with IBI evaluated in nine hospitals in China (January 2012 - August 2019). Antibiotic resistance patterns of pathogens responsible for neonatal IBIs were analyzed.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Of 3770 full-term neonates who were subjected to lumbar puncture and a blood culture, IBIs were diagnosed in 460 neonates (12.2%). <em>Escherichia coli</em> and Group B <em>Streptococcus</em> (GBS) were the leading pathogens, followed by <em>Enterococcus spp</em>, and <em>Staphylococcus aureus</em>. <em>Escherichia coli</em> expressed high resistance to ampicillin (72.0%) and third-generation cephalosporins (cefotaxime, 34.8%; ceftriaxone, 38.1%). The prevalence of extended spectrum beta-lactamase (ESBL)-producing <em>Escherichia coli</em> was 34.1%. The proportions of <em>Enterococcus spp</em> resistant to penicillin and ampicillin were 60% and 54.1%. All <em>Staphylococcus aureus</em> showed resistance to ampicillin and penicillin. The resistance rate of <em>Staphylococcus aureus</em> to methicillin was 50%. Although all GBS were susceptible to penicillin and ampicillin, the proportions of GBS resistant to erythromycin and clindamycin were 75.9% and 77.3%. Antibiotic susceptibility appeared to improve in 2019. Susceptibility of <em>Escherichia coli</em> to ampicillin, cefotaxime, and ceftriaxone improved to 42.9%, 76.9%, and 71.4% in 2019, compared with 12.5%, 37.5%, and 50% in 2012. The prevalence of ESBL-producing <em>Escherichia coli</em> declined to 20% in 2019, lower than 100% in 2012. Susceptibility of GBS to erythromycin and clindamycin improved from 0% in 2012 to 28.6% and 25% in 2019.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>The prevalence of antibiotic resistance is high in neonates in China, although there is a favorable declining trend in recent years.</p>

immunology,infectious diseases,microbiology
Etiology of severe invasive infections in young infants in rural settings in sub-Saharan Africa

Estomih Mduma,Tinto Halidou,Berenger Kaboré,Thomas Walongo,Palpouguini Lompo,Justine Museveni,Joshua Gidabayda,Jean Gratz,Godfrey Guga,Caroline Kimathi,Jie Liu,Paschal Mdoe,Robert Moshiro,Max Petzold,Jan Singlovic,Martine Guillerm,Melba F. Gomes,Eric R. Houpt,Christine M. Halleux

DOI: https://doi.org/10.1371/journal.pone.0264322

IF: 3.7

2022-02-25

PLoS ONE

Abstract:Background Serious invasive infections in newborns are a major cause of death. Lack of data on etiological causes hampers progress towards reduction of mortality. This study aimed to identify pathogens responsible for such infections in young infants in sub-Saharan Africa and to describe their antibiotics resistance profile. Methods Between September 2016 and April 2018 we implemented an observational study in two rural sites in Burkina Faso and Tanzania enrolling young infants aged 0–59 days old with serious invasive infection. Blood samples underwent blood culture and molecular biology. Results In total 634 infants with clinical diagnosis of serious invasive infection were enrolled and 4.2% of the infants had a positive blood culture. The most frequent pathogens identified by blood culture were Klebsiella pneumonia and Staphylococcus aureus , followed by Escherichia coli . Gram-negative isolates were only partially susceptible to first line WHO recommended treatment for neonatal sepsis at community level. A total of 18.6% of the infants were PCR positive for at least one pathogen and Escherichia coli and Staphylococcus aureus were the most common bacteria detected. Among infants enrolled, 60/634 (9.5%) died. Positive blood culture but not positive PCR was associated with risk of death. For most deaths, no pathogen was identified either by blood culture or molecular testing, and hence a causal agent remained unclear. Mortality was associated with low body temperature, tachycardia, respiratory symptoms, convulsions, history of difficult feeding, movement only when stimulated or reduced level of consciousness, diarrhea and/or vomiting. Conclusion While Klebsiella pneumonia and Staphylococcus aureus , as well as Escherichia coli were pathogens most frequently identified in infants with clinical suspicion of serious invasive infections, most cases remain without definite diagnosis, making more accurate diagnostic tools urgently needed. Antibiotics resistance to first line antibiotics is an increasing challenge even in rural Africa.

multidisciplinary sciences

Neonatal sepsis and antibiotic resistance in developing countries.

Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries

Prevalence of Multidrug-Resistant Pathogens Causing Neonatal Early and Late Onset Sepsis, a Retrospective Study from the Tertiary Referral Children’s Hospital

Neonatal sepsis in low-income countries: epidemiology, diagnosis and prevention

Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries

Neonatal Sepsis Due to Multidrug-resistant Bacteria at a Tertiary Teaching Hospital in Ethiopia

Gram-Negative Neonatal Sepsis in Low- and Middle- Income Countries: How Appropriate are the WHO Recommended Empirical Sepsis Antibiotic Regimens? A Systematic Review and Meta-Analysis

Etiology of Bacterial Sepsis and Isolate Resistance Patterns in Hospitalized Neonates in Zambia

Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome

Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis

Introduction to injury and repair of microbial cells.

Changing Landscape of Antimicrobial Resistance in Neonatal Sepsis: An in silico Analyses of Multidrug Resistance in Klebsiella pneumoniae

Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria

Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients.

Identification of potential novel combination antibiotic regimens based on drug-susceptibility and genetic diversity of Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries

Efficient solutions in V-KT-pseudoinvex multiobjective control problems: A characterization

The current and future roles of neonatal infection surveillance programmes in combating antimicrobial resistance

Neonatal bacteremia in a neonatal intensive care unit: analysis of causative organisms and antimicrobial susceptibility

Technical considerations when obtaining and interpreting prostatic biopsies from men with suspicion of early prostate cancer: Part I

Antibiotic resistance in neonates in China 2012–2019: A multicenter study

Etiology of severe invasive infections in young infants in rural settings in sub-Saharan Africa